Researchers study the functions of B4GALT3 in cancer immunity
An old campaign slogan for cough syrup, "It tastes awful. And it works," seemed to imply that any sweet content might have diminished the medicinal effect.
Oct 26, 2023
0
0
An old campaign slogan for cough syrup, "It tastes awful. And it works," seemed to imply that any sweet content might have diminished the medicinal effect.
Oct 26, 2023
0
0
For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor panitumumab results in longer progression-free survival ...
Oct 24, 2023
0
0
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further ...
Oct 23, 2023
0
0
Targeted treatment with the fibroblast growth factor receptor (FGFR) inhibitor erdafitinib improved responses and overall survival compared to standard chemotherapy for patients with metastatic urothelial cancers with FGFR ...
Oct 23, 2023
0
0
A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating ...
Oct 23, 2023
0
0
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously ...
Oct 22, 2023
0
1
A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study ...
Oct 22, 2023
0
0
Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient's chances for surviving long term, according to a study presented at the American College of Surgeons ...
Oct 20, 2023
0
0
There are significant gaps in the UK public's awareness of the telltale signs and symptoms of cancer in children and teens, with just a third of adults expressing confidence in being able to recognize them, find the results ...
Oct 16, 2023
0
0
Combining a PD-1 immune checkpoint inhibitor with standard chemotherapy improved quality of life for patients with advanced stomach cancer or esophageal cancer compared to chemotherapy alone, according to recent findings ...
Oct 12, 2023
0
1